3 Results for "

ipatasertib+gdc+0068

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ipatasertib+gdc+0068" in MCE Product Catalog:

69
69 Cited Publications
Art. -Nr.: HY-15186
CAS. Nr.: 1001264-89-6
Reinheit:  99.79%
Synonyms: GDC-0068; RG7440
Target:  

Organoid Akt Apoptosis

Forschungsgebiete:  

Cancer

Ipatasertib (GDC-0068) is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models .
loading...
    loading...
Art. -Nr.: HY-15186C
CAS. Nr.: 1491138-24-9
Synonyms: GDC-0068 tosylate; RG7440 tosylate
Target:  

Organoid Akt Apoptosis

Forschungsgebiete:  

Cancer

Ipatasertib (GDC-0068) tosylate is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib tosylate synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib tosylate also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models .
loading...
    loading...
Art. -Nr.: HY-15186R
CAS. Nr.: 1001264-89-6
Synonyms: GDC-0068 (Standard); RG7440 (Standard)
Ipatasertib (Standard) is the analytical standard of Ipatasertib (HY-15186). This product is intended for research and analytical applications. Ipatasertib (GDC-0068) is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models .
loading...
    loading...